Abstract:Immune homeostasis depends upon effective clearance of pathogens while simultaneously preventing autoimmunity and immunopathology in the host. Restimulation-induced cell death (RICD) is one such mechanism where by activated T cells receive subsequent antigenic stimulation, reach a critical signal threshold through the T cell receptor (TCR), and commit to apoptosis. Many details of this process remain unclear, including the role of co-stimulatory and co-inhibitory proteins that influence the TCR signaling cascade. Here we characterize the role of T cell immunoglobulin and mucin domain containing 3 (TIM-3) in RICD regulation. TIM-3 protected newly activated CD8+ effector T cells from premature RICD during clonal expansion. Surprisingly, however, we found that TIM-3 potentiated RICD in late-stage effector T cells. The presence of TIM-3 increased proximal TCR signaling and proapoptotic protein expression in late-stage effector T cells, with no consistent signaling effects noted in newly activated cells with or without TIM-3. To better explain these differences in TIM-3 function as T cells aged, we characterized the temporal pattern of TIM-3 expression in effector T cells. We found that TIM-3 was expressed on the surface of newly activated effector T cells, but remained largely intracellular in late-stage effector cells. Consistent with this, TIM-3 required a ligand to prevent early RICD, whereas ligand manipulation had no effects at later stages. Of the known TIM-3 ligands, carcinoembryonic antigen-related cell adhesion molecule (CEACAM1) showed the greatest difference in surface expression over time and also protected newly activated cells from premature RICD, with no measurable effects in late-stage effectors. Indeed, CEACAM1 enabled TIM-3 surface expression on T cells, implying a co-dependency for these proteins in protecting expanding T cells from premature RICD. Our findings suggest that co-signaling proteins like TIM-3 and CEACAM1 can alter RICD sensitivity at different stages of the effector T cell response, with important implications for checkpoint blockade therapy.

Sensitivity to Restimulation-Induced Cell Death Is Linked to Glycolytic Metabolism in Human T Cells

Consensus guidelines for the detection of immunogenic cell death.

PD-1 protects expanding human T cells from premature restimulation-induced cell death.

Cutting edge: Rac GTPases sensitize activated T cells to die via Fas

TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1

SAP Facilitates Recruitment and Activation of LCK at NTB-A Receptors during Restimulation-Induced Cell Death

Transient FOXP3 upregulation protects human conventional T cells from restimulation-induced cell death during activation-induced proliferation

Reductive carboxylation epigenetically instructs T cell differentiation

Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity

Suppression of glycolysis decreases sugar-induced cell death in Saccharomyces cerevisiae.

Co-receptor (CD4/CD8) engagement enhances CD3-induced apoptosis in thymocytes. Implications for negative selection.

Coupled feedback regulation of nuclear factor of activated T-cells (NFAT) modulates activation-induced cell death of T cells

The death receptor Fas mediates a non-apoptotic signaling cascade in apoptosis resistant CD4+ T cells via the MAPK pathway. (P1304)

Lactate Limits T Cell Proliferation via the NAD(H) Redox State

Peripheral self-reactivity regulates antigen-specific CD8 T-cell responses and cell division under physiological conditions

Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death

Involvement of Cellular Death in Trail/Dr5-Dependent Suppression Induced by Cd4(+)Cd25(+) Regulatory T Cells

Activation-induced and damage-induced cell death in aging human T cells

Coordinated ARP2/3 and glycolytic activities regulate the morphological and functional fitness of human CD8+ T cells

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes